National Vision Holdings, Inc. Net Income (Loss) Available to Common Stockholders, Diluted
National Vision Holdings, Inc. (EYE) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$65.90 million for the 12-month period ending 2023-12-30, per its 10-K filed 2024-02-27.
Discontinued › Income Statement
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2024-02-27
- National Vision Holdings, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2023-12-30 was -$15.99M.
- National Vision Holdings, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2023-09-30 was -$73.80M, a 741.61% decline year-over-year.
- National Vision Holdings, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2023-07-01 was $5.61M, a 42.33% decline year-over-year.
- National Vision Holdings, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2023-04-01 was $20.63M, a 36.51% decline year-over-year.
- National Vision Holdings, Inc. net income (loss) available to common stockholders, diluted for fiscal 2023 was -$65.90M, a 256.45% decline from fiscal 2022.
- National Vision Holdings, Inc. net income (loss) available to common stockholders, diluted for fiscal 2022 was $42.12M, a 69.42% decline from fiscal 2022.
- National Vision Holdings, Inc. net income (loss) available to common stockholders, diluted for fiscal 2022 was $137.73M, a 279.65% increase from fiscal 2021.
- National Vision Holdings, Inc. net income (loss) available to common stockholders, diluted for fiscal 2021 was $36.28M, a 10.61% increase from fiscal 2019.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2023-12-30 | -$15.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$89.78M derived: sum of 2 quarters · filed 2024-02-27 | -$84.17M derived: sum of 3 quarters · filed 2024-02-27 | -$65.90M 10-K · filed 2024-02-27 |
| 2023-09-30 | -$73.80M 10-Q · filed 2023-11-09 | -$68.18M derived: sum of 2 quarters · filed 2023-11-09 | -$49.91M 10-Q · filed 2023-11-09 | -$63.94M derived: sum of 4 quarters · filed 2024-02-27 |
| 2023-07-01 | $5.61M 10-Q · filed 2023-08-10 | $23.88M 10-Q · filed 2023-08-10 | $9.86M derived: sum of 3 quarters · filed 2024-02-27 | $21.36M derived: sum of 4 quarters · filed 2024-02-27 |
| 2023-04-01 | $20.63M 10-Q · filed 2023-05-11 | $4.24M derived: sum of 2 quarters · filed 2024-02-27 | $15.74M derived: sum of 3 quarters · filed 2024-02-27 | $25.48M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-12-31 | -$16.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$4.89M derived: sum of 2 quarters · filed 2024-02-27 | $4.85M derived: sum of 3 quarters · filed 2024-02-27 | $42.12M 10-K · filed 2024-02-27 |
| 2022-10-01 | $11.50M 10-Q · filed 2023-11-09 | $21.24M derived: sum of 2 quarters · filed 2023-11-09 | $58.51M 10-Q · filed 2023-11-09 | $62.34M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-02 | $9.73M 10-Q · filed 2023-08-10 | $44.60M 10-Q · filed 2023-08-10 | $50.84M derived: sum of 3 quarters · filed 2024-02-27 | $94.23M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-02 | $32.49M 10-Q · filed 2023-05-11 | $41.11M derived: sum of 2 quarters · filed 2024-02-27 | $84.49M derived: sum of 3 quarters · filed 2024-02-27 | $124.45M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-01-01 | $8.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $52.00M derived: sum of 2 quarters · filed 2024-02-27 | $91.96M derived: sum of 3 quarters · filed 2024-02-27 | $137.73M 10-K · filed 2024-02-27 |
| 2021-10-02 | $43.38M 10-Q · filed 2022-11-10 | $83.35M derived: sum of 2 quarters · filed 2022-11-10 | $129.11M 10-Q · filed 2022-11-10 | $164.19M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-07-03 | $39.96M 10-Q · filed 2022-08-11 | $85.73M 10-Q · filed 2022-08-11 | $120.81M derived: sum of 3 quarters · filed 2023-03-01 | $156.09M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-04-03 | $45.76M 10-Q · filed 2022-05-10 | $80.84M derived: sum of 2 quarters · filed 2023-03-01 | $116.13M derived: sum of 3 quarters · filed 2023-03-01 | $72.30M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-01-02 | $35.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $70.37M derived: sum of 2 quarters · filed 2023-03-01 | $26.54M derived: sum of 3 quarters · filed 2023-03-01 | $36.28M 10-K · filed 2023-03-01 |
| 2020-09-26 | $35.29M 10-Q · filed 2021-11-10 | -$8.54M derived: sum of 2 quarters · filed 2021-11-10 | $1.20M 10-Q · filed 2021-11-10 | |
| 2020-06-27 | -$43.83M 10-Q · filed 2021-08-12 | -$34.09M 10-Q · filed 2021-08-12 | ||
| 2020-03-28 | $9.74M 10-Q · filed 2021-05-13 | |||
| 2019-12-28 | $32.80M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |